Myocardial Infarction: Clinical Trials

27 trials for Myocardial Infarction, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

27 terminated. 27 Phase 3, 8 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 327Terminated 27
Phase 28Terminated 8

Follow Myocardial Infarction: new trials by email Literature Review of Myocardial Infarction trials Research Report on Myocardial Infarction

Trials (filtered) newest first · largest first

All 27 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effect of Low-dose Intracoronary Reteplase on Myocardial Infarct Size During Primary Percutaneous Coronary Intervention
Normal Saline, Reteplase Injection 9mg, Reteplase Injection 18mg - Acute ST-segment Elevation Myocardial Infarction
Phase 3TerminatedGe Junbo362021-07-012023-09-14
COLchicine to Prevent Sympathetic Denervation After an Acute Myocardial Infarction
Colchicine - Myocardial Infarction, Acute
Phase 2 / Phase 3TerminatedUniversity Hospital, Montpellier542020-12-042026-06-12
Effect of Methotrexate Carried by a Lipid Nanoemulsion on Left Ventricular Remodeling After STEMI
Methotrexate, Placebo, Folic Acid - Myocardial Infarction, Anterior Wall, Myocardial Remodeling, Ventricular
Phase 2 / Phase 3TerminatedUniversity of Sao Paulo352018-04-172021-01-11
Effect of DLBS1033 After Primary PCI in Patients With STE-ACS
DLBS1033, Placebo, Standard therapy - ST Elevation Myocardial Infarction
Phase 2 / Phase 3TerminatedDexa Medica Group232016-11-012023-09-08
Bivalirudin Infusion for Ventricular Infarction Limitation
PPCI, Bivalirudin, Heparin - Acute Myocardial Infarction
Phase 3TerminatedThe Medicines Company782014-12-192018-10-05
Multi-cap for Increase Adherence After Acute Myocardial Infarction
Combined capsule, Conventional therapy - Myocardial Infarction
Phase 3TerminatedHospital El Cruce1002014-04-012017-01-11
Prasugrel and Ticagrelor in ST-segment Elevation Myocardial Infarction
Prasugrel 60 mg, Ticagrelor 180 mg - ST-Segment Elevation Myocardial Infarction
Phase 3TerminatedDong-A University392014-01-012017-08-18
The Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects
bococizumab (PF-04950615), Placebo - Cardiovascular Disease
Phase 3TerminatedPfizer105642013-10-292019-05-01
The Evaluation of Bococizumab (PF-04950615;RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects
bococizumab (PF-04950615), Placebo - Cardiovascular Disease
Phase 3TerminatedPfizer167842013-10-292018-07-11
Stentys Coronary Stent System Clinical Trial in Patients With Acute Myocardial Infarction
STENTYS self-apposing stent, VISION balloon-expandable stent - Acute Myocardial Infarction
Phase 3TerminatedStentys3182013-05-012017-04-20
A Multinational Trial To Evaluate The Parachute Implant System
Parachute Implant - Heart Failure, Myocardial Infarction
Phase 3TerminatedCardioKinetix, Inc592011-05-012017-06-23
Safety and Efficacy of AIN457 in Patients With Quiescent Non-infectious Uveitis
AIN457, Placebo - Non-infectious Uveitis
Phase 3TerminatedNovartis Pharmaceuticals862010-08-012016-01-14
Aliskiren Effect on Aortic Plaque Progression
Aliskiren, Placebo - Atherosclerosis
Phase 2 / Phase 3TerminatedOhio State University712009-10-012017-05-11
Intramyocardial Transplantation of Bone Marrow Stem Cells in Addition to Coronary Artery Bypass Graft (CABG) Surgery
CD133+ autologous bone marrow stem cell, Placebo - Myocardial Ischemia, Coronary Artery Disease
Phase 3TerminatedMiltenyi Biotec B.V. & Co. KG812009-07-012020-07-15
The Effect Of Acadesine On Reducing Cardiovascular and Cerebrovascular Adverse Events In Coronary Artery Bypass Graft (CABG) Surgery (Study P05633 AM1)(TERMINATED)
Acadesine, Normal Saline - Coronary Artery Bypass, Myocardial Infarction
Phase 3TerminatedMerck Sharp & Dohme LLC30802009-04-012015-10-29
ThromboAblation in Acute Myocardial Infarction
Laser Thromboablation, PTCA (Direct Stenting) - ST Elevation Acute Myocardial Infarction
Phase 2 / Phase 3TerminatedKCRI782008-03-012011-01-20
Clopidogrel and the Optimization of Gastrointestinal Events (COGENT-1)
CGT-2168 (clopidogrel 75 mg/omeprazole 20 mg) and aspirin, Plavix (clopidogrel 75 mg) and aspirin - Acute Coronary Syndrome, Myocardial Infarction
Phase 3TerminatedCogentus Pharmaceuticals50002007-12-012009-01-28
Trial to Assess the Effects of Vorapaxar (SCH 530348; MK-5348) in Preventing Heart Attack and Stroke in Particpants With Acute Coronary Syndrome (TRA•CER) (Study P04736)
Vorapaxar, Placebo - Atherosclerosis, Myocardial Ischemia
Phase 3TerminatedMerck Sharp & Dohme LLC129442007-12-012018-09-21
Eptifibatide and ST Segment Resolution Following Primary PCI
eptifibitide - Myocardial Infarction
Phase 3TerminatedMedstar Health Research Institute222007-08-012014-08-11
Cell Therapy in Myocardial Infarction
Autologous Bone Marrow Mononuclear Cells (ABMMC) Transplantation - Acute Myocardial Infarction
Phase 2 / Phase 3TerminatedMinistry of Health, Brazil1662006-07-012017-03-30

Showing 20 of 27. Sign in to see all of them.

Narrower conditions

ST Elevation Myocardial Infarction (9)  ·  Cardiovascular Diseases (6)  ·  Stroke (6)  ·  Acute Coronary Syndrome (4)  ·  Myocardial Ischemia (4)  ·  Atherosclerosis (3)  ·  Coronary Artery Disease (2)  ·  Heart Diseases (2)  ·  Heart Failure (2)  ·  Hyperlipidemias (2)  ·  Non-ST Elevated Myocardial Infarction (2)  ·  Ventricular Remodeling (2)  ·  Anterior Wall Myocardial Infarction (1)  ·  Cerebrovascular Disorders (1)

Broader conditions

Infarction (27)  ·  Ischemia (27)  ·  Necrosis (27)  ·  Pathologic Processes (27)  ·  Pathological Conditions, Signs and Symptoms (27)  ·  Vascular Diseases (27)  ·  Heart Diseases (25)  ·  Myocardial Ischemia (23)  ·  Cardiovascular Diseases (21)  ·  Central Nervous System Diseases (8)  ·  Nervous System Diseases (8)  ·  Brain Diseases (7)  ·  Cerebrovascular Disorders (6)  ·  Arterial Occlusive Diseases (5)

Interventions

Aspirin (2)  ·  Clopidogrel (2)  ·  Saline Solution (2)  ·  bococizumab (2)  ·  Colchicine (1)  ·  DLBS 1033 (1)  ·  Eptifibatide (1)  ·  Folic Acid (1)  ·  Heparin (1)  ·  Methotrexate (1)  ·  Niacin (1)  ·  Omeprazole (1)  ·  Prasugrel Hydrochloride (1)  ·  Rimonabant (1)  ·  Simvastatin (1)

Sponsors

Merck Sharp & Dohme LLC (2)  ·  Pfizer (2)  ·  The Medicines Company (2)  ·  Arginox Pharmaceuticals (1)  ·  Axio Research. LLC (1)  ·  CardioKinetix, Inc (1)  ·  Cogentus Pharmaceuticals (1)  ·  Dexa Medica Group (1)  ·  Dong-A University (1)  ·  Ge Junbo (1)  ·  Hospital El Cruce (1)  ·  KCRI (1)  ·  M.D. Anderson Cancer Center (1)  ·  Mayo Clinic (1)  ·  Medstar Health Research Institute (1)

Countries

United States (13)  ·  France (7)  ·  Germany (7)  ·  Brazil (6)  ·  Canada (6)  ·  Netherlands (6)  ·  Israel (5)  ·  Poland (5)  ·  United Kingdom (5)  ·  Argentina (4)  ·  Australia (4)  ·  Chile (4)  ·  Czechia (4)  ·  Hungary (4)  ·  India (4)

Top investigators

Deepak L. Bhatt, MD (2)  ·  Aline G. Ferrari, MD (1)  ·  Andrew P Levy, MD PhD (1)  ·  Carlos Tajer, MD (1)  ·  Chen Shapira, MD (1)  ·  Dariusz Dudek, MD, PhD (1)  ·  Eric Topol, MD (1)  ·  Gustav Steinhoff, M.D. (1)  ·  Hans F Dohmann, MD (1)  ·  Jean-Bernard Durand, MD (1)  ·  Jeffrey Probstfield, MD (1)  ·  Judith S. Hochman, M.D. (1)  ·  Junbo Ge (1)

Results publications

PMID 28304242, PMID 29685591, PMID 29716940, PMID 35277540, PMID 17387132, PMID 18032779, PMID 19699853, PMID 19915221, PMID 20709233, PMID 20925534, PMID 20976246, PMID 22077816, PMID 22085343, PMID 22305835, PMID 22747980, PMID 22782417, PMID 23537969, PMID 23686372, PMID 23881958, PMID 23916935, PMID 23973688, PMID 24152824, PMID 24211500, PMID 24402559, PMID 25012288, PMID 25037310, PMID 25129064, PMID 25218533, PMID 25440792, PMID 25959558, PMID 26025218, PMID 26089177, PMID 26708287, PMID 27012778, PMID 27151345, PMID 27162212, PMID 27502866, PMID 27902833, PMID 28382371, PMID 28781130, PMID 28988157, PMID 29627296, PMID 29632238, PMID 29910052, PMID 30371334, PMID 32186246, PMID 32629392, PMID 34134520, PMID 35196863, PMID 35224730

NIH funding

2005 (1), 2009 (1), U01HL081616 (1), U01HL081649 (1)